These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31305991)

  • 1. gH625 Cell-Penetrating Peptide Promotes the Endosomal Escape of Nanovectorized siRNA in a Triple-Negative Breast Cancer Cell Line.
    Ben Djemaa S; Hervé-Aubert K; Lajoie L; Falanga A; Galdiero S; Nedellec S; Soucé M; Munnier E; Chourpa I; David S; Allard-Vannier E
    Biomacromolecules; 2019 Aug; 20(8):3076-3086. PubMed ID: 31305991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and in vitro evaluation of a siRNA delivery nanosystem decorated with gH625 peptide for triple negative breast cancer theranosis.
    Ben Djemaa S; David S; Hervé-Aubert K; Falanga A; Galdiero S; Allard-Vannier E; Chourpa I; Munnier E
    Eur J Pharm Biopharm; 2018 Oct; 131():99-108. PubMed ID: 30063968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-targeted pH/redox dual-sensitive unimolecular nanoparticles for efficient siRNA delivery.
    Chen G; Wang Y; Xie R; Gong S
    J Control Release; 2017 Aug; 259():105-114. PubMed ID: 28159516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. siRNA-loaded poly(histidine-arginine)
    Sun P; Huang W; Kang L; Jin M; Fan B; Jin H; Wang QM; Gao Z
    Int J Nanomedicine; 2017; 12():3221-3234. PubMed ID: 28458542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-delivery of EGFR and BRD4 siRNA by cell-penetrating peptides-modified redox-responsive complex in triple negative breast cancer cells.
    Zhang C; Yuan W; Wu Y; Wan X; Gong Y
    Life Sci; 2021 Feb; 266():118886. PubMed ID: 33310044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-penetrating peptide-conjugated lipid nanoparticles for siRNA delivery.
    Asai T; Tsuzuku T; Takahashi S; Okamoto A; Dewa T; Nango M; Hyodo K; Ishihara H; Kikuchi H; Oku N
    Biochem Biophys Res Commun; 2014 Feb; 444(4):599-604. PubMed ID: 24486551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly penetrating nanobubble polymer enhances LINC00511-siRNA delivery for improving the chemosensitivity of triple-negative breast cancer.
    Yuan Y; Li E; Zhao J; Wu B; Na Z; Cheng W; Jing H
    Anticancer Drugs; 2021 Feb; 32(2):178-188. PubMed ID: 32826414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing Endosomal Escape for Intracellular Delivery of Macromolecular Biologic Therapeutics.
    Lönn P; Kacsinta AD; Cui XS; Hamil AS; Kaulich M; Gogoi K; Dowdy SF
    Sci Rep; 2016 Sep; 6():32301. PubMed ID: 27604151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinational siRNA delivery using hyaluronic acid modified amphiphilic polyplexes against cell cycle and phosphatase proteins to inhibit growth and migration of triple-negative breast cancer cells.
    Parmar MB; Meenakshi Sundaram DN; K C RB; Maranchuk R; Montazeri Aliabadi H; Hugh JC; Löbenberg R; Uludağ H
    Acta Biomater; 2018 Jan; 66():294-309. PubMed ID: 29183848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic nanocarriers for the specific delivery of siRNA: Contribution of breast cancer cells active targeting for down-regulation efficiency.
    Bruniaux J; Allard-Vannier E; Aubrey N; Lakhrif Z; Ben Djemaa S; Eljack S; Marchais H; Hervé-Aubert K; Chourpa I; David S
    Int J Pharm; 2019 Oct; 569():118572. PubMed ID: 31352052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trileucine residues in a ligand-CPP-based siRNA delivery platform improve endosomal escape of siRNA.
    Ullah I; Chung K; Beloor J; Kim J; Cho M; Kim N; Lee KY; Kumar P; Lee SK
    J Drug Target; 2017 Apr; 25(4):320-329. PubMed ID: 27820977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-functionalized graphene oxide for enhanced siRNA delivery to breast cancer cells.
    Imani R; Shao W; Taherkhani S; Emami SH; Prakash S; Faghihi S
    Colloids Surf B Biointerfaces; 2016 Nov; 147():315-325. PubMed ID: 27543693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel cell-penetrating peptide-loaded nanobubbles synergized with ultrasound irradiation enhance EGFR siRNA delivery for triple negative Breast cancer therapy.
    Jing H; Cheng W; Li S; Wu B; Leng X; Xu S; Tian J
    Colloids Surf B Biointerfaces; 2016 Oct; 146():387-95. PubMed ID: 27388967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing siRNA-based cancer therapy using a new pH-responsive activatable cell-penetrating peptide-modified liposomal system.
    Xiang B; Jia XL; Qi JL; Yang LP; Sun WH; Yan X; Yang SK; Cao DY; Du Q; Qi XR
    Int J Nanomedicine; 2017; 12():2385-2405. PubMed ID: 28405163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endosomolytic and Tumor-Penetrating Mesoporous Silica Nanoparticles for siRNA/miRNA Combination Cancer Therapy.
    Wang Y; Xie Y; Kilchrist KV; Li J; Duvall CL; Oupický D
    ACS Appl Mater Interfaces; 2020 Jan; 12(4):4308-4322. PubMed ID: 31939276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational modification of oligoarginine for highly efficient siRNA delivery: structure-activity relationship and mechanism of intracellular trafficking of siRNA.
    Chu D; Xu W; Pan R; Ding Y; Sui W; Chen P
    Nanomedicine; 2015 Feb; 11(2):435-46. PubMed ID: 25193363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stealth magnetic nanocarriers of siRNA as platform for breast cancer theranostics.
    Bruniaux J; Djemaa SB; Hervé-Aubert K; Marchais H; Chourpa I; David S
    Int J Pharm; 2017 Nov; 532(2):660-668. PubMed ID: 28506802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted nanomedicine with anti-EGFR scFv for siRNA delivery into triple negative breast cancer cells.
    Nguyen PV; Hervé-Aubert K; David S; Lautram N; Passirani C; Chourpa I; Aubrey N; Allard-Vannier E
    Eur J Pharm Biopharm; 2020 Dec; 157():74-84. PubMed ID: 33059006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice.
    Guo J; Cheng WP; Gu J; Ding C; Qu X; Yang Z; O'Driscoll C
    Eur J Pharm Sci; 2012 Apr; 45(5):521-32. PubMed ID: 22186295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deciphering the internalization mechanism of WRAP:siRNA nanoparticles.
    Deshayes S; Konate K; Dussot M; Chavey B; Vaissière A; Van TNN; Aldrian G; Padari K; Pooga M; Vivès E; Boisguérin P
    Biochim Biophys Acta Biomembr; 2020 Jun; 1862(6):183252. PubMed ID: 32135145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.